Quick Comparison
| NAC (N-Acetyl Cysteine) | PQQ | |
|---|---|---|
| Half-Life | 5.6 hours | 3-5 hours (plasma), but effects on mitochondrial biogenesis persist |
| Typical Dosage | Standard: 600-1800 mg daily in 2-3 divided doses. For psychiatric applications: 1200-2400 mg daily (under medical supervision). Take on an empty stomach for best absorption. Can cause nausea — take with a small amount of food if needed. | Standard: 10-20 mg daily. Often combined with CoQ10 (100-300 mg) for synergistic mitochondrial support. Higher doses (40 mg) are used in some research settings. |
| Administration | Oral (capsules, powder). Take on empty stomach or with light food. Effervescent tablets also available. | Oral (capsules, softgels). Best absorbed on an empty stomach. BioPQQ is the most studied branded form. |
| Research Papers | 10 papers | 10 papers |
| Categories |
Mechanism of Action
NAC (N-Acetyl Cysteine)
NAC provides cysteine, the rate-limiting substrate for glutathione (GSH) synthesis via gamma-glutamylcysteine ligase (GCLC) and glutathione synthetase (GSS). GSH is the primary intracellular antioxidant, essential for GPx and GST-mediated detoxification of reactive oxygen species in neurons. NAC also modulates glutamate via the cystine-glutamate antiporter (System Xc-, composed of xCT and 4F2hc) — NAC is deacetylated to cysteine, which exchanges for glutamate; the increased extracellular cystine is reduced to cysteine intracellularly, while the exchange increases extrasynaptic glutamate, which activates inhibitory mGlu2/3 autoreceptors on presynaptic terminals, reducing excessive glutamatergic signaling and compulsive behaviors. This glutamate modulation is the basis for psychiatric applications (OCD, addiction). NAC may also directly modulate NMDA receptors via redox sites.
PQQ
PQQ activates PGC-1alpha (peroxisome proliferator-activated receptor gamma coactivator 1-alpha), the master transcriptional regulator of mitochondrial biogenesis. PGC-1alpha coactivates NRF-1 and NRF-2, which drive expression of mitochondrial transcription factor A (TFAM) and nuclear-encoded mitochondrial genes—the process of creating new mitochondria in existing cells. This is unique among commercially available supplements. PQQ also provides antioxidant protection through extremely efficient redox cycling at the N5 position; it can undergo thousands of oxidation-reduction cycles before being exhausted, estimated at 5,000x the efficiency of vitamin C. PQQ activates the CREB (cAMP response element-binding protein) signaling pathway and may enhance NGF signaling, supporting BDNF expression, synaptic plasticity, and neuronal survival.
Risks & Safety
NAC (N-Acetyl Cysteine)
Common
Nausea, diarrhea, unpleasant sulfur smell/taste.
Serious
May be harmful in certain contexts — there is concern it could protect cancer cells from oxidative stress. May interact with nitroglycerin (dangerous blood pressure drop).
Rare
Bronchospasm in asthmatics (when inhaled).
PQQ
Common
Very few — PQQ has an excellent safety profile at standard doses. Mild headache, fatigue initially.
Serious
No serious adverse effects documented.
Rare
Insomnia, irritability.
Full Profiles
NAC (N-Acetyl Cysteine) →
The acetylated form of the amino acid L-cysteine and the most effective oral supplement for raising glutathione — the body's master antioxidant. NAC has an unusually broad range of evidence-based applications: it is used as a prescription drug for acetaminophen overdose, as a mucolytic, and as an adjunct treatment for OCD, addiction, and bipolar disorder. In nootropics, it protects neurons from oxidative stress and modulates glutamate.
PQQ →
Pyrroloquinoline quinone is a redox cofactor that is the only known compound that can stimulate the growth of new mitochondria (mitochondrial biogenesis) in existing cells. Since mitochondrial density and function decline with age, PQQ addresses a root cause of age-related cognitive decline. It also provides potent antioxidant protection — estimated to be 5,000x more efficient at redox cycling than vitamin C.